Pennock - Overview and Barriers

download Pennock - Overview and Barriers

of 15

Transcript of Pennock - Overview and Barriers

  • 8/9/2019 Pennock - Overview and Barriers

    1/36

    Basic Clinical Immunology

    Overview

    Dr Joanne PennockSchool of Translational Medicine

    [email protected]

  • 8/9/2019 Pennock - Overview and Barriers

    2/36

    Recommended reading:

    Essential of Clinical Immunology

    Chapel, Haeney, Misbah & Snowdon (Authors)

    5th Ed 2006, Blackwell Scientific Publications

    Janeway’s Immunobiology 

    Kenneth Murphy

    Garland Science 2011

    http://www.amazon.co.uk/Janeways-Immunobiology-Kenneth-Murphy/dp/0815342438/ref=sr_1_1?s=books&ie=UTF8&qid=1318926114&sr=1-1http://www.amazon.co.uk/gp/reader/1405127619/ref=sib_dp_pt

  • 8/9/2019 Pennock - Overview and Barriers

    3/36

    Immunology timeline:

    Ancient

    Civilisations

    430BC – 

    8 th Century

    accination

    GermTheory1800’s  1900’s 

  • 8/9/2019 Pennock - Overview and Barriers

    4/36

    •Sprang from the study of bacteria and

    smallpox

    •Bacteria first observed…. •Idea of ‘contagion’ gradually evolved 

    •1718 Lady Mary Wortley Montagu

    innoculated her children against smallpox

    (Constantinople)

    •1798 Edward Jenner successfully

    demonstrated innoculation against smallpox

    •1884 Koch’s postulates – definition of a

    contagious disease

    GermTheory

    1800’s 

    Vaccination

  • 8/9/2019 Pennock - Overview and Barriers

    5/36

    1900’s  •Discovery of mouse MHC

    • Advances in microscopy

    •Louis Pasteur developed rabies

    and anthrax vaccines – first

    example of attenuating bacteriato induce immunity

    • Antigen:antibody theory

    established

    •Hypersensitivity and allergy

  • 8/9/2019 Pennock - Overview and Barriers

    6/36

    Clonal selection theoryHLA

     Antibody structure

    Thymus

    T & B cells

    Dendritic cells

    HIVcytokines

    Immune response to intra/extracellular

    pathogens (Th1 vs Th2)

    Regulatory T cells

    Danger model

    pattern recognition (TLR)

  • 8/9/2019 Pennock - Overview and Barriers

    7/36

    •37 interleukins•Th17 cells

    •Native and inducible T reg cells

    •Human papillomavirus vaccine

    •Regulatory macrophages and DCs……. 

  • 8/9/2019 Pennock - Overview and Barriers

    8/36

    Barriers to infection

  • 8/9/2019 Pennock - Overview and Barriers

    9/36

    The skin:

    3 layers protect the body from infection.

    Collagen

    between

    layers

  • 8/9/2019 Pennock - Overview and Barriers

    10/36

    Epidermolysis bullosa

    Caused by a defect in collagen formation

  • 8/9/2019 Pennock - Overview and Barriers

    11/36

     Atopic dermatitis

    Often associated with mutations in Filaggrin

    Secondary infections cause ‘flare ups’ due to

    breach of skin barrier

  • 8/9/2019 Pennock - Overview and Barriers

    12/36

    The lungs:

    Dr Keith Wheeler/ Science photo library

    Healthy lung

    tissue

  • 8/9/2019 Pennock - Overview and Barriers

    13/36

    The lungs:

    Cystic fibrosis

     A severe disease causingexcessive mucus production in

    the lungs and pancreatic ducts.

    Life expectancy 30 years.

    Normal CF

    Excessive mucusimpairs bacterial

    clearance resulting in

    congestion and severe

    infection.

  • 8/9/2019 Pennock - Overview and Barriers

    14/36

    The gastrointestinal tract:

    Saliva, mucus, antibodies

    and constant surveillance

    protect the body frompathogens

  • 8/9/2019 Pennock - Overview and Barriers

    15/36

    The stomach:

    Gastric/duodenal ulcers

    caused by:NSAIDS (20%)

    H pylori (80%)

    Protection of gastric

    epithelium by mucusand secretion of

    neutralising

    bicarbonate

  • 8/9/2019 Pennock - Overview and Barriers

    16/36

    The colon:

    In the GI tract, a single layer of cells separates our

    immune system from the outside world

  • 8/9/2019 Pennock - Overview and Barriers

    17/36

    The firm mucus layer is devoid of bacteria.

    Johansson M E V et al. PNAS 2008;105:15064-15069

    ©2008 by National Academy of Sciences

    The colon:

     A protective layerof mucus is

    essential for

    health

  • 8/9/2019 Pennock - Overview and Barriers

    18/36

    Johansson M E V et al. PNAS 2008;105:15064-15069

    The colon:

    Mucus is secretedby goblet cells

  • 8/9/2019 Pennock - Overview and Barriers

    19/36

    Muc5ac: a critical component

    mediating the rejection of entericnematodes.

    J Exp Med. 2011 May 9;208(5):893-900. Epub 2011 Apr 18. 

    Hasnain SZ, Evans CM, Roy M, Gallagher AL, Kindrachuk KN, Barron L,

    Dickey BF, Wilson MS, Wynn TA, Grencis RK, Thornton DJ.

    Wellcome Trust Centre for Cell Matrix Research, Faculty of LifeSciences, The University of Manchester, Manchester M13 9PT,

    England, UK.

    http://www.ncbi.nlm.nih.gov/pubmed?term=%22Hasnain%20SZ%22%5BAuthor%5Dhttp://www.ncbi.nlm.nih.gov/pubmed?term=%22Evans%20CM%22%5BAuthor%5Dhttp://www.ncbi.nlm.nih.gov/pubmed?term=%22Roy%20M%22%5BAuthor%5Dhttp://www.ncbi.nlm.nih.gov/pubmed?term=%22Gallagher%20AL%22%5BAuthor%5Dhttp://www.ncbi.nlm.nih.gov/pubmed?term=%22Kindrachuk%20KN%22%5BAuthor%5Dhttp://www.ncbi.nlm.nih.gov/pubmed?term=%22Barron%20L%22%5BAuthor%5Dhttp://www.ncbi.nlm.nih.gov/pubmed?term=%22Dickey%20BF%22%5BAuthor%5Dhttp://www.ncbi.nlm.nih.gov/pubmed?term=%22Wilson%20MS%22%5BAuthor%5Dhttp://www.ncbi.nlm.nih.gov/pubmed?term=%22Wynn%20TA%22%5BAuthor%5Dhttp://www.ncbi.nlm.nih.gov/pubmed?term=%22Grencis%20RK%22%5BAuthor%5Dhttp://www.ncbi.nlm.nih.gov/pubmed?term=%22Thornton%20DJ%22%5BAuthor%5Dhttp://www.ncbi.nlm.nih.gov/pubmed?term=%22Thornton%20DJ%22%5BAuthor%5Dhttp://www.ncbi.nlm.nih.gov/pubmed?term=%22Grencis%20RK%22%5BAuthor%5Dhttp://www.ncbi.nlm.nih.gov/pubmed?term=%22Wynn%20TA%22%5BAuthor%5Dhttp://www.ncbi.nlm.nih.gov/pubmed?term=%22Wilson%20MS%22%5BAuthor%5Dhttp://www.ncbi.nlm.nih.gov/pubmed?term=%22Dickey%20BF%22%5BAuthor%5Dhttp://www.ncbi.nlm.nih.gov/pubmed?term=%22Barron%20L%22%5BAuthor%5Dhttp://www.ncbi.nlm.nih.gov/pubmed?term=%22Kindrachuk%20KN%22%5BAuthor%5Dhttp://www.ncbi.nlm.nih.gov/pubmed?term=%22Gallagher%20AL%22%5BAuthor%5Dhttp://www.ncbi.nlm.nih.gov/pubmed?term=%22Roy%20M%22%5BAuthor%5Dhttp://www.ncbi.nlm.nih.gov/pubmed?term=%22Evans%20CM%22%5BAuthor%5Dhttp://www.ncbi.nlm.nih.gov/pubmed?term=%22Hasnain%20SZ%22%5BAuthor%5D

  • 8/9/2019 Pennock - Overview and Barriers

    20/36

    Johansson M E V et al. PNAS 2008;105:15064-15069

    The colon:

    Upper layer ofmucus is

    colonised by

    bacteria

  • 8/9/2019 Pennock - Overview and Barriers

    21/36

    The colon:

    Gut flora provides additional barrierEssential for health and development

    Different composition between individuals

    Thought to ‘out compete’ potential pathogens 

    •‘Mutaflor’ 

    •Ulcerative Colitis

    •Gastroenteritis

    •IBS

    •Pouchitis

    •Crohn’s disease 

    Each capsule 2.5-25x10(9) viable cells

  • 8/9/2019 Pennock - Overview and Barriers

    22/36

    The colon:

    Gut flora is actively involved in thehomeostasis and maintenance of health in the

    gut

    http://iai.asm.org/

  • 8/9/2019 Pennock - Overview and Barriers

    23/36

    World's largest E. coli  outbreak

    kills 14 in Germany (May 2011)3,500 infected

    855 developed rare haemolytic uraemic syndrome

    53 died

    Enteroaggregative

    strain of E. co li  had

    acquired Shiga toxin

    which caused HUS

    E. Coli is a commenal bacterium 

    •Species is highly diverse

    • Acquisition of virulence genes canlead to pathogenicity 

  • 8/9/2019 Pennock - Overview and Barriers

    24/36

    The gastrointestinal tract:

    IgA is a GI specific

    antibody

    responsible for

    primary defenceagainst bacteria

  • 8/9/2019 Pennock - Overview and Barriers

    25/36

    http://www.calier.es/

    The gastrointestinal tract: IgA

  • 8/9/2019 Pennock - Overview and Barriers

    26/36

    •1 in 700 Europeans are IgA deficient

    •The most common immunodeficiency

    •Many have no symptoms…. BUT 

    Role of IgA in the defense against

    respiratory infections: IgA deficient mice

    exhibited increased susceptibility to

    intranasal infection with Mycobacterium

    bovis BCG

    Vaccine 

    Volume 23, Issue 20, 8 April 2005, Pages 2565-2572

    •IgA deficient patients suffer more episodes of:

    •bronchitis•pneumonia

    •chronic diarrhea

    •conjunctivitis

    •sinusitis

    •IgA deficiency often presents with IgG2 deficiency

    •Increases susceptibility to certain bacteria

    http://www.sciencedirect.com/science/journal/0264410Xhttp://www.sciencedirect.com/science?_ob=PublicationURL&_hubEid=1-s2.0-S0264410X00X03271&_cid=271205&_pubType=JL&view=c&_auth=y&_acct=C000228598&_version=1&_urlVersion=0&_userid=10&md5=faaf8c6c12a88c4ae410f96ac8fd1e0bhttp://www.sciencedirect.com/science/journal/0264410Xhttp://www.sciencedirect.com/science?_ob=PublicationURL&_hubEid=1-s2.0-S0264410X00X03271&_cid=271205&_pubType=JL&view=c&_auth=y&_acct=C000228598&_version=1&_urlVersion=0&_userid=10&md5=faaf8c6c12a88c4ae410f96ac8fd1e0bhttp://www.sciencedirect.com/science/journal/0264410X

  • 8/9/2019 Pennock - Overview and Barriers

    27/36

    The bladder:No mucosal layer

    ‘Umbrella’ cells provide barrier function alongside 5to 6 cell-deep epithelium

  • 8/9/2019 Pennock - Overview and Barriers

    28/36

    Leonardo da vinci 1510 Circulatory system

    Discovery of blood & lymph systems

    Lymphatic system

  • 8/9/2019 Pennock - Overview and Barriers

    29/36

    ©2006 Encyclopedia Britannica

    Lymph and blood systems are separate

     Antigen: substance which provokes an immune responseMay have several antigenic determinants (epitopes)

    which can be recognised by antibody

    Therefore a single antigen may provoke many antibody molecules

     Antibody: Soluble factor secreted by plasma cell in large quantities

    Prevents antigen from causing damage (inflammation)

    Cytokine: Protein secreted by cells of the immune system to

    orchestrate the immune response (activate, suppress,attract)

  • 8/9/2019 Pennock - Overview and Barriers

    30/36

    …But lymph and blood interact at lymph nodes 

  • 8/9/2019 Pennock - Overview and Barriers

    31/36

    http://effleurageholistictherapies.co.uk

    Lymph nodes are the defence hub during infection

    e.g. Head and neck lymph nodes during flu

  • 8/9/2019 Pennock - Overview and Barriers

    32/36

    Swelling of lymph nodes during infection is due

    to cellular proliferation, and antibody production.

  • 8/9/2019 Pennock - Overview and Barriers

    33/36

     Any immune response is very much an

    orchestrated event involving early non-

    specific defence, quickly followed by non-specific attack, then antigen-specific, site-

    specific defence.

  • 8/9/2019 Pennock - Overview and Barriers

    34/36

     Any immune response is very much an

    orchestrated event involving early non-

    specific defence, quickly followed by non-specific attack, then antigen-specific, site-

    specific defence.

  • 8/9/2019 Pennock - Overview and Barriers

    35/36

     Any immune response is very much an

    orchestrated event involving early non-

    specific defence, quickly followed by non-specific attack, then antigen-specific, site-

    specific defence.

  • 8/9/2019 Pennock - Overview and Barriers

    36/36

     Any immune response is very much an

    orchestrated event involving early non-

    specific attack, quickly followed by antigen-specific, site-specific defence.